Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Mayo Clinic proceedings

• Publication date

  1988-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0025-6196(12)65097-6PMID 3278174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.

  1987cited by this paper
• Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems.

  1986cited by this paper
• Improved Chromatography of Cyclosporine

  1986cited by this paper
• Current status of renal transplantation--1986.

  1986cited by this paper
• A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.

  1986cited by this paper
• INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS

  1985cited by this paper
• Morphological patterns in cyclosporine-treated renal transplant recipients.

  1985cited by this paper
• Newer clinical protocols of immunosuppression

  1985cited by this paper
• Cyclosporine: five years' experience in cadaveric renal transplantation.

  1984cited by this paper
• Cyclosporine-associated chronic nephropathy.

  1984cited by this paper
• Temperature dependency of apparent cyclosporin A concentrations in plasma.

  1983cited by this paper
• Intravenous cyclosporine kinetics in renal failure

  1983cited by this paper
• Temperature dependency of cyclosporin plasma levels.

  1983cited by this paper
• Cyclosporine immunosuppression.

  1983cited by this paper
• Cyclosporine nephrotoxicity.

  1983cited by this paper
• A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

  1983cited by this paper
• Temperature dependency of cyclosporin plasma levels.

  1983cited by this paper
• The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.

  1982cited by this paper
• IMMUNOPHARMACOLOGICAL MONITORING OF CYCLOSPORIN A‐TREATED RECIPIENTS OF CADAVERIC KIDNEY ALLOGRAFTS

  1982cited by this paper
• Liquid-chromatographic determination of cyclosporin A in blood and plasma.

  1981cited by this paper
• A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

  1981cited by this paper
• Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase.

  1977cited by this paper
• Single subcutaneous injection of iothalamate sodium I 125 to measure glomerular filtration rate.

  1976cited by this paper
• Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase.

  1976cited by this paper
• Measurement of total alkaline phosphatase activity in human serum.

  1975cited by this paper
• Letter: Osteomalacia and femoral fractures.

  1974cited by this paper
• Creatinine assay by a reaction-kinetic principle.

  1972cited by this paper

• Establishment of operational tolerance to sustain antitumor immunotherapy.

  2022cites this paper
• Simultaneous Determination of Everolimus, Sirolimus, Tacrolimus, and Cyclosporine-A by Mass Spectrometry.

  2020cites this paper
• Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications

  2019cites this paper
• Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultrafast LC-MS/MS.

  2018cites this paper
• Immune responses in the aquatic gastropod Lymnaea stagnalis under short-term exposure to pharmaceuticals of concern for immune systems: Diclofenac, cyclophosphamide and cyclosporine A.

  2017cites this paper
• Combination of glucosamine improved therapeutic effect of low‐dose cyclosporin A in patients with atopic dermatitis: A pilot study

  2013cites this paper
• Tumors of the Parapharyngeal Space

  2009cites this paper
• Advances in immunosuppressive therapy.

  2007cites this paper
• Advances in Immunosuppressive Therapy

  2007cites this paper
• Therapeutic monitoring of cyclosporin — an update

  2004cites this paper
• Toxic effects of imm U flO 5 U ppressive drugs : mechanisms and strategies for controlling them

  2004cites this paper
• Pediatric Transplant Patients and Their Medical Conditions / Therapies : Implications for Perioperative Management

  2004cites this paper
• Nephrotoxic drugs

  2004cites this paper
• The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

  2003cites this paper
• Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer.

  2002cites this paper
• Cyclosporin trough levels: is monitoring necessary during short‐term treatment in psoriasis? A systematic review and clinical data on trough levels

  2002cites this paper
• PRODUCT MONOGRAPH

  2000cites this paper
• Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.

  2000cites this paper
• Gender‐dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers

  2000cites this paper
• Impact of early cyclosporin average blood concentration on early kidney transplant failure

  1998cites this paper
• Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.

  1998cites this paper
• Cyclosporine Trough Concentrations in Predicting Allograft Rejection and Renal Toxicity up to 12 Months after Renal Transplantation

  1998cites this paper
• UvA-DARE ( Digital Academic Repository ) Homologous testis transplantation in dogs

  1997cites this paper
• [Conversion from +Sandimmune to Neoral in kidney transplant recipients treated with cyclosporine and ketoconazole].

  1997cites this paper
• Homologous testis transplantation in dogs

  1997cites this paper
• Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them.

  1996cites this paper
• Early results of infrageniculate arterial reconstruction using cryopreserved homograft saphenous conduit (CADVEIN) and combination low-dose systemic immunosuppression.

  1996cites this paper
• A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.

  1996cites this paper
• Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral.

  1996cites this paper
• The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy

  1996cites this paper
• Acute renal and immunological effects of low-dose cyclosporin in humans.

  1995cites this paper
• Optimizing the use of cyclosporine in renal transplantation.

  1995cites this paper
• [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].

  1995cites this paper
• Cyclosporine A: Clinical Experience and Therapeutic Drug Monitoring

  1995cites this paper
• Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans

  1995cites this paper
• The therapeutic window of cyclosporine in Chinese recipients of renal transplantation.

  1995cites this paper
• Sandimmun neoral pharmacokinetics: impact of the new oral formulation.

  1995cites this paper
• Cyclosporin in renal transplantation: a 9 year experience.

  1995cites this paper
• Measurement of OG37-325 by high-performance liquid chromatography.

  1994cites this paper
• Individualization of cyclosporine therapy in renal transplantation.

  1994cites this paper
• Pharmacokinetic behavior of cyclosporine A in liver dysfunction.

  1994cites this paper
• Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans

  1994cites this paper
• Multiple drug overdose in a kidney transplant patient.

  1994cites this paper
• Methodological and Clinical Aspects of Cyclosporin Monitoring: Report of the Association of Clinical Biochemists Task Force

  1994cites this paper
• Importance of cytochrome P‐450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients

  1994cites this paper
• Clinical Correlations of Cyclosporine‐Specific and ‐Nonspecific Assays in Stable Renal Transplants, Acute Rejection, and Cyclosporine Nephrotoxicity

  1993cites this paper
• Cyclosporin Clinical Pharmacokinetics

  1993cites this paper
• Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation

  1993cites this paper
• 24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications.

  1993cites this paper
• Cyclosporin‐induced hypertension precedes renal dysfunction and sodium retention in man

  1993cites this paper
• Pediatric heart transplantation: Complications

  1993cites this paper
• Task force 5: Complications

  1993cites this paper
• Cyclosporin monitoring: its role in autoimmune indications.

  1992cites this paper
• [Modalities of therapeutic follow-up of cyclosporine].

  1992cites this paper
• A review of assay methods for cyclosporin. Clinical implications.

  1992cites this paper
• Optimal Use of Sandimmun® in Nephrotic Syndrome

  1992cites this paper
• A Review of Assay Methods for Cyclosporin

  1992cites this paper
• Comparison of Nonspecific Radioimmunoassay, High‐Performance Liquid Chromatography, and Fluorescence Polarization Immunoassay for Cyclosporine Monitoring in Renal Transplantation

  1991cites this paper
• Complications Associated with Immunosuppressive Therapy and Their Management

  1991cites this paper
• Therapeutic monitoring for cyclosporine: difficulties in establishing a therapeutic window.

  1991cites this paper
• Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine.

  1991cites this paper
• Factors influencing the pharmacokinetics of cyclosporine in man.

  1991cites this paper
• Pediatric heart transplantation at Stanford: results of a 15-year experience.

  1991cites this paper
• Monitoring of the free concentration of cyclosporine in plasma in man

  1991cites this paper
• Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.

  1991cites this paper
• Assay methods for cyclosporine monitoring following liver transplantation

  1990cites this paper
• Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.

  1990cites this paper
• Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.

  1990cites this paper
• Pediatric heart transplantation.

  1990cites this paper
• Summary on therapeutic drug monitoring for renal transplantation.

  1990cites this paper
• Laboratory monitoring of cyclosporine levels: guidelines for the dermatologist.

  1990cites this paper
• Current status of renal transplantation.

  1990cites this paper
• The erythromycin breath test as a predictor of cyclosporine blood levels

  1990cites this paper
• Comparison of the utility of 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients.

  1990cites this paper
• A prospective study of cyclosporine monitoring in renal transplantation.

  1990cites this paper
• Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel.

  1990cites this paper
• Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.

  1990cites this paper
• Cyclosporine monitoring.

  1989cites this paper
• Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring.

  1989cites this paper
• Cyclosporine nephrotoxicity.

  1989cites this paper
• Pharmacology of cyclosporine (sandimmune). I. Introduction.

  1989cites this paper
• Cyclosporine A and hypertension.

  1988cites this paper
• ČETRDESET GODINA CIKLOSPORINA U KLINIČKOJ PRAKSI FORTY YEARS OF CYCLOSPORINE IN CLINICAL PRACTICE

  year unknowncites this paper